Plasma adenosine deaminase activity and macrophage polarization markers in TNBC patients before and after cancer treatment. The activity of plasma total ADA (tADA, A), ADA1 (B), ADA2 (C), and concentration of plasma soluble CD163 (sCD163, D) and galectin-3 (Gal3, E) in triple negative breast cancer (TNBC) patients before (n = 19), 6-months (6 mths, n = 6) and 12-months (12 mths, n = 4) after surgical intervention followed by chemotherapy. Results are shown as mean ± SEM and analyzed by Kruskal-Wallis test followed by Dunn’s post hoc test (A,B,E) and one-way ANOVA followed by Holm-Sidak post hoc test (C,D).